Legal Representation
Attorney
Jong Park
USPTO Deadlines 0 active
All 4 deadline(s) have been cleared by subsequent events.
No active deadlines at this time.
Application History
28 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 30, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 30, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 26, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jul 25, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jul 11, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jul 5, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 14, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jun 14, 2022 | IUAF | S | USE AMENDMENT FILED |
| Mar 22, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 23, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Dec 22, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 22, 2021 | ALIE | A | ASSIGNED TO LIE |
| Dec 21, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Dec 21, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 21, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 19, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 19, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 19, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jul 23, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 23, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 23, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 23, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 14, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 13, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 16, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells
First Use Anywhere:
Jan 7, 2021
First Use in Commerce:
Apr 27, 2022
Class 042
Product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, namely, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics
First Use Anywhere:
Jan 7, 2022
First Use in Commerce:
Apr 27, 2022
Additional Information
Design Mark
The mark consists of the word of "GIPICA" in black and two circles connected to each other on the above the letter "A", wherein the two connected circles have the designed portions in black, red and blue, and a white background color is not part of the mark.
Color Claim
The color(s) black, red and blue is/are claimed as a feature of the mark.
Classification
International Classes
005
042